MedPath

PREVALENCE OF LOW BACK PAIN AT TERTIARY LEVEL

Not yet recruiting
Conditions
Other specified acquired deformities of musculoskeletal system,
Registration Number
CTRI/2020/11/029385
Lead Sponsor
Dr Nandini Sharma
Brief Summary

All patients of low back pain visiting pain clinic or OPD and willing to participate will be explained about the purpose of this study and thereafter written informed consent will be taken. A performa will be filled for all patients willing to participate. Baseline data will be elicited with questions regarding demographic characterstics, physical health, psychological health, psychosocial work environment, lifestyle factors, and sick leave. Anthropometric measurements including height and weight will be included and BMI calculated. Record of relevant investigations according to patient’s profile such as complete heamogram with erythrocyte sedimentation rate, blood sugar, renal function tests, vitamin D levels, X rays, MRI, CT scan ,TFT etc. will be entered in the performa.

Participants will be inquired if they have any chronic disease like diabetes, hypertension, heart disease, kidney disease, cancer, arthritis, liver disease, asthma, COPD or any other chronic disease.

All the treatment received by the patient from the very first visit will be recorded. Lifestyle modification will be advised to the patients such as weight loss, correct posture during work, cessation of smoking and alcohol, diet rich in vitamin D and calcium etc. Patients will be followed up or contacted telephonically for atleast 3 months after every 2 weeks to evaluate them for any improvement in low back pain or deterioration of symptoms. Further any investigations and intervention if needed in case there is no improvement will be advised on subsequent visits.  If LBP is persisting for more than 3 months duration then it will be considered and managed as chronic low back pain.

Low back pain severity will be measured based on 0-10 (with 0 as no pain and 10 repersenting the

worst pain) VAS. Pain severity was further categorized as:

MILD (1-3)

MODERATE (4-5)

SEVERE (6-7)

VERY SEVERE (8-9)

EXCRUCIATING PAIN (10)

 Socio economic status was assessed using modified kuppuswamy scale based on education, occupation

of head of family and per capita income of family.

UPPER CLASS (Score 26-29)

UPPER MIDDLE (Score 16-25)

LOWER MIDDLE (Score 11-15)

UPPER LOWER (Score 5-10)

LOWER (below 5)

 BMI classification:

<18.5(underweight)

18.5-24.9(normal range)

25-29.9(overweight)

>30 (obese)                   class 1 (30-34.9)       class 2 (35-39.9)           class3 (≥40)

  Severity of vitamin D will be grouped as (in ng/ml):

PROFOUND DEFICIENCY (≤4)

SEVERE DEFICIENCY (5-8)

MODERATELY SEVERE DEFICIENCY (9-12)

MODERATE DEFICIENCY (13-16)

MARGINAL DEFICIENCY (17-20)

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
290
Inclusion Criteria

Pts with low back pain.

Exclusion Criteria

Pts not willing Bedridden pts Pts with major psychiatric illness.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To prevent acute low back pain to chronic low back painThe results of the research is to estimate the prevalence of low back pain during 12 months period | To evaluate common risk factors of low back pain | To prevent acute low back pain to chronic low back pain
To evaluate common risk factors of low back painThe results of the research is to estimate the prevalence of low back pain during 12 months period | To evaluate common risk factors of low back pain | To prevent acute low back pain to chronic low back pain
The results of the research is to estimate the prevalence of low back painThe results of the research is to estimate the prevalence of low back pain during 12 months period | To evaluate common risk factors of low back pain | To prevent acute low back pain to chronic low back pain
Secondary Outcome Measures
NameTimeMethod
etiology of low back painimpact of low back pain on individual quality of life

Trial Locations

Locations (1)

Dr.RPGMC tanda

🇮🇳

Kangra, HIMACHAL PRADESH, India

Dr.RPGMC tanda
🇮🇳Kangra, HIMACHAL PRADESH, India
Dr Bharti Gupta
Principal investigator
9418044928
drbharti203@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.